The latest numbers from the World Health Organization (WHO) report that obesity affects Results of a phase 3 clinical trial recently published in The New England Journal of Medicine demonstrate Top-line results from this phase 3 clinical trial had originally been reported in April 2024 and found tirzepatide helps reduce symptom severity by almost two-thirds in adults with obesity and obstructive sleep apnea
A consolidated leave plan pools vacation, sick, and personal days into a single paid-time-off bank that employees draw from as needed
Ready to improve your sleep and support your metabolism
$45 Vitamin C Promote skin health and improve appearance of fine lines and wrinkles
Monitoring recommendations Researchers using cagrilintide should consider regular monitoring including: Blood work every 3 to 6 months including metabolic panel, lipid panel, liver function, and pancreatic enzymes Thyroid function tests at baseline and periodically Body composition assessment to track lean mass versus fat mass changes Heart rate monitoring particularly during titration Nutritional status markers including vitamin B12, iron, and vitamin D The peptide research and studies section provides broader context for evaluating emerging safety data as it becomes available
Your body had just adapted to the previous level of slowing, and now it needs to adapt again